Elevated on-treatment levels of serum IFN-gamma is associated with treatment failure of peginterferon plus ribavirin therapy for chronic hepatitis C

MLA

Nai-Jen Hou, et al. “Elevated On-Treatment Levels of Serum IFN-Gamma Is Associated with Treatment Failure of Peginterferon plus Ribavirin Therapy for Chronic Hepatitis C.” Scientific Reports, Mar. 2016. EBSCOhost, https://doi.org/10.1038/srep22995.

APA

Nai-Jen Hou, Jee-Fu Huang, Meng-Hsuan Hsieh, Yi-Hung Lin, Ming-Lun Yeh, Chung-Feng Huang, Ching-I Huang, Ming-Ying Lu, Chia-Yen Dai, Shinn-Cherng Chen, Wan-Long Chuang, Po-Cheng Liang, Shu-Chi Wang, Zu-Yau Lin, Ming-Yen Hsieh, & Ming-Lung Yu. (2016). Elevated on-treatment levels of serum IFN-gamma is associated with treatment failure of peginterferon plus ribavirin therapy for chronic hepatitis C. Scientific Reports. https://doi.org/10.1038/srep22995

Chicago

Nai-Jen Hou, Jee-Fu Huang, Meng-Hsuan Hsieh, Yi-Hung Lin, Ming-Lun Yeh, Chung-Feng Huang, Ching-I Huang, et al. 2016. “Elevated On-Treatment Levels of Serum IFN-Gamma Is Associated with Treatment Failure of Peginterferon plus Ribavirin Therapy for Chronic Hepatitis C.” Scientific Reports, March. doi:10.1038/srep22995.